Delivery Order SPE2DB22D2206-SPE2DB26FDT71
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,940.63 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $107,643.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product, with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $89,703.15 firm fixed price delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is unclassified as a set-aside and has an ultimate completion date of September 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,960.42 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $119,604.20 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and designates Conshohocken, Pennsylvania as the place of performance, which serves as AmerisourceBergen's corporate headquarters. The delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $87,253.24 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This firm fixed-price, non-set-aside contract is set to be completed by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $149,505.25 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This firm fixed price contract, awarded September 26, 2025, with an ultimate completion date of October 20, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a $23,920.84 delivery order to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $11,960.42 firm fixed price delivery order for DARZALEX FASPRO 1,800MG-30,000 15ML, with an ultimate completion date of July 8, 2025. This competitively awarded contract, which carries no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical product. This is a firm fixed-price delivery order valued at $89,703.15, with an ultimate completion date of October 15, 2025. The contract involves no set-aside designation and represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDT71Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $89,703.00 to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product for military and federal healthcare systems. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's headquarters location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. This delivery order falls under the company's comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and enables the supply of a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs globally. The DLA Troop Support is developing next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards, positioning AmerisourceBergen as a key participant in federal pharmaceutical supply chain management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.7k | 10/24/25 |